Shrestha, R. (2020). Induced pluripotent stem cells are Japanese brand sources for therapeutic cells to pretrial clinical research. Progress in Stem Cell, 7(1), 296-303. https://doi.org/https://doi.org/10.15419/psc.v7i1.409